Skip to main content
FDA Shortage Check

Is Midazolam Hydrochloride Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Midazolam Hydrochloride Injecti…: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Delay in shipping of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Fresenius Kabi USA, LLC, Oct 15, 2026
DRUG
Midazolam Hydrochloride Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Apr 2, 2020
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 27 presentations: 8 unavailable · 3 limited · 16 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Midazolam Hydrochloride Injection. 27 presentations from 6 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Fresenius Kabi USA, LLC7 presentations · 3 unavailable · 4 available or not stated

Contact (FDA's listing): 888-386-1300

  • 2 mg/2 mL

    Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)

    Next release November 2026. Check wholesalers for inventory.

    NDC 76045-211-20Reverified

    Unavailable

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)

    Estimated recovery: TBD

    NDC 63323-411-10Reverified

    Unavailable

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10)

    Estimated recovery: TBD

    NDC 63323-412-10Reverified

    Unavailable

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)

    Check wholesalers for inventory

    NDC 63323-411-12Reverified

    Available

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)

    Check wholesalers for inventory

    NDC 63323-411-25Reverified

    Available

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)

    Check wholesalers for inventory

    NDC 63323-412-02Reverified

    Available

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)

    Check wholesalers for inventory

    NDC 63323-412-25Revised

    Available

Gland Pharma Limited2 presentations · 2 unavailable

Contact (FDA's listing): Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)

    Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals

    NDC 25021-655-02Reverified

    Unavailable

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)

    Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals

    NDC 25021-661-10Reverified

    Unavailable

Hospira, Inc., a Pfizer Company8 presentations · 3 unavailable · 3 limited · 2 available or not stated

Contact (FDA's listing): 844-646-4398

  • 10 mg/2 mL (5 mg/mL)

    Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)

    Next Delivery: November 2026; Estimated Recovery: December 2026

    NDC 0409-2308-02Revised

    Unavailable

  • 5 mg/mL (5 mg/mL)

    Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)

    Next Delivery: November 2026; Estimated Recovery: December 2026

    NDC 0409-2308-01Revised

    Unavailable

  • 10 mg/10 mL (1 mg/mL)

    Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)

    Next Delivery: January 2027; Estimated Recovery: March 2027

    NDC 0409-2587-05Revised

    Unavailable

  • 2 mg/2mL (1 mg/mL)

    Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25)

    Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: March 2027

    NDC 0409-0001-25Revised

    Limited Availability

  • 2 mg/2mL (1 mg/mL)

    Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)

    Next Estimated Delivery and Estimated Recovery: December 2026

    NDC 0409-2305-17Reverified

    Limited Availability

  • 5 mg/5 mL (1 mg/mL)

    Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)

    Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027

    NDC 0409-2305-05Revised

    Limited Availability

  • 25 mg/5 mL (5 mg/mL)

    Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)

    NDC 0409-2596-03Reverified

    Available

  • 50 mg/10 mL (5 mg/mL)

    Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)

    NDC 0409-2596-05Reverified

    Available

Avet Pharmaceuticals, Inc.3 presentations · 3 available or not stated

Contact (FDA's listing): 855-228-9470

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)

    NDC 23155-600-41Reverified

    Available

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41)

    NDC 23155-601-41Reverified

    Available

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42)

    NDC 23155-601-42Reverified

    Available

Hikma Pharmaceuticals USA, Inc.5 presentations · 5 available or not stated

Contact (FDA's listing): 800-631-2174

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6056-10Reverified

    Available

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6057-25Reverified

    Available

  • 1 mg/1 mL

    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6059-01Reverified

    Available

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6060-10Reverified

    Available

  • 5 mg/1 mL

    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6061-25Reverified

    Available

WG Critical Care2 presentations · 2 available or not stated

Contact (FDA's listing): 888-493-0861

  • 1 mg/1 mL

    Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)

    Please check wholesalers and distributors for inventory.

    NDC 44567-610-10Reverified

    Available

  • 1 mg/1 mL

    Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)

    Please check wholesalers and distributors for inventory.

    NDC 44567-611-10Reverified

    Available

What the manufacturers told FDA

  • Fresenius Kabi USA, LLC · ‘Estimated recovery: TBD’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Next release November 2026. Check wholesalers for inventory.’ · updated Oct 2026
  • Gland Pharma Limited · ‘Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: March 2027’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Delay in shipping of the drug
  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Midazolam Hydrochloride Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Midazolam Hydrochloride Injection as currently in shortage: 27 presentations, 8 unavailable and 3 limited.
When will the Midazolam Hydrochloride Injection shortage end?
FDA gives no end date. 10 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Midazolam Hydrochloride Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.